Polycystic ovary syndrome (PCOS) is a complex endocrine disorder that affects many aspects of women’s health during reproductive age. The disease is characterized by ovulation disorders, hyperandrogenism, and enlarged ovaries. Hormonal, metabolic, and genetic factors influence the pathologies. The main clinical manifestations of PCOS are irregular menstruation, infertility, excessive hair growth on the body and face (hirsutism), as well as acne and decreased insulin sensitivity. PCOS is one of the most common causes of infertility in women and can contribute to the development of serious complications, including type 2 diabetes, hypertension, and cardiovascular disease.
History of the disease and interesting historical facts
The first descriptions of polycystic ovary syndrome were provided in the early 20th century, when medical research became more systematic. In 1935, doctors Irwin Kosinski and Edward Polyanas reviewed the main clinical manifestations and identified the presence of multiple ovarian cysts. However, the current understanding of PCOS has changed significantly over time. In the 1990s, the multifaceted nature of the syndrome was recognized, including its metabolic component and its relationship with insulin resistance. The study of PCOS continues to evolve, with an emphasis on genetic markers and molecular mechanisms of this pathology, allowing for more precise recommendations for women with this diagnosis.
Epidemiology
According to the latest data, the prevalence of polycystic ovary syndrome among women of reproductive age varies from 6 to 15%. At the same time, different populations demonstrate different levels of morbidity. The main SPKYA syndrome can be identified in up to 70% women suffering from infertility. According to statistics, about 40% women with PCOS have pronounced symptoms of insulin resistance, which is associated with the possible development of metabolic syndrome and concomitant diseases. More in-depth epidemiological studies indicate the importance of preventive and therapeutic measures aimed at reducing the manifestations of this syndrome and improving the overall health of patients.
Genetic predisposition to this disease
Genetic predisposition to polycystic ovary syndrome has a significant impact on the development of the disease. Many studies have found a link between PCOS and several genes involved in the regulation of ovulation and metabolism. In particular, genes such as FSHR, LHB and INSR have shown an association with the risk of the disease. Studies also indicate the presence of hereditary traits such as increased androgen levels and persistent insulin resistance. Couples of patients with a history of PCOS often have similar clinical manifestations, which confirms the possibility of genetic transmission of predisposition.
Risk factors for the development of this disease
Risk factors that contribute to the development of polycystic ovary syndrome include the following:
- Heredity - the presence of cases of the disease in the family.
- Overweight and obesity, which leads to metabolic disorders.
- High levels of androgens, which can manifest as hirsutism and acne.
- Psycho-emotional stress can worsen symptoms and metabolic disorders.
- A sedentary lifestyle accompanied by low physical activity.
- A diet high in carbohydrates and fats that causes insulin resistance.
Recognition of these risk factors is key to the prevention and timely management of PCOS.
Diagnosis of this disease
Diagnosis of polycystic ovary syndrome includes the following sequence of actions:
— **Main symptoms:** irregular menstruation, acne, hirsutism, infertility, weight gain.
— **Laboratory tests:** measurement of hormone levels such as testosterone, follicle-stimulating hormone and luteinizing hormone, as well as insulin and glucose tests.
— **Radiological examinations:** ultrasound examination of the pelvic organs to detect the presence of cysts in the ovaries.
— **Other diagnostics:** blood lipid assessment and other metabolic tests.
— **Differential diagnosis:** exclusion of other causes of endocrine disorders, such as hypothyroidism and hyperprolactinemia.
Characteristic clinical manifestations and research results are the basis for the correct diagnosis of PCOS.
Treatment
Treatment for polycystic ovary syndrome may include:
— **General treatment:** Lifestyle changes aimed at weight loss and increased physical activity.
— **Pharmacological treatment:** use of oral contraceptives to regulate the menstrual cycle and reduce androgen levels; metformin drugs to improve insulin sensitivity.
— **Surgical treatment:** laparoscopic ovarioplasty or ovarian drainage surgery for high degrees of insulin resistance.
— **Other treatments:** use of antiandrogen agents and drugs to improve menstrual function.
The combination of different treatment methods allows achieving optimal results and improving the quality of life of patients with PCOS.
List of medications used to treat this disease
The list of medications for the treatment of polycystic ovary syndrome includes:
- Metformin
- Clostilbegit
- Oral contraceptives (eg, ethinyl estradiol in combination with a progestin)
- Spironolactone
- Duphaston (progesterone)
Each of these drugs has its own indications, contraindications and side effects, and should be used as prescribed by a doctor.
Disease monitoring
Monitoring for polycystic ovary syndrome includes:
— **Control stages:** regular examinations by a gynecologist and endocrinologist, tests for hormones and carbohydrate metabolism.
— **Prognosis:** With proper lifestyle modifications and medication, many women are able to become pregnant and maintain normal health.
— **Complications:** Without treatment, metabolic disorders, infertility, endometriosis and an increased risk of cardiovascular disease may develop.
Constant monitoring helps reduce the likelihood of complications and improve the quality of life of patients.
Age-related features of the disease
Polycystic ovary syndrome can present differently in different age groups:
- In adolescents: may significantly affect the menstrual cycle, which becomes apparent from the moment of the first menstruation.
— In women of reproductive age: infertility and possible difficulties in conceiving become more frequent.
- In older women: the risk of developing concomitant diseases such as diabetes and hypertension increases.
An individual approach to treatment and monitoring of the condition is important at every stage of the life cycle.
Questions and Answers
- What is polycystic ovary syndrome? It is an endocrine disorder that causes menstrual irregularities and can lead to infertility.
- What are the main symptoms of PCOS? Irregular menstruation, hirsutism, acne, weight gain and infertility.
- How is PCOS diagnosed? Using hormone analysis, ultrasound examination of the pelvic organs and assessment of metabolic parameters.
- How is PCOS treated? Treatment involves lifestyle changes, medications and, in some cases, surgery.
- Is there a genetic predisposition to PCOS? Yes, heredity does matter, as the chances of developing the disease are higher in women whose close relatives suffered from PCOS.
